CAH · News · 20260805N

Competition and Market Share

CARDINAL HEALTH INC · 2026-08-05 · Importance 17 · Surprise 24

Cardinal Health, McKesson, and Cencora collectively control more than 90% of the U.S. drug distribution market, indicating a highly concentrated domestic wholesaling structure. Cencora’s specialty assets are reportedly performing strongly and helping offset industry headwinds. McKesson is also benefiting from specialty pharmaceuticals, oncology services, and prescription-volume growth, reinforcing specialty distribution as a key competitive battleground.

Key facts

• Cardinal Health shares rose by 2.43% to $239.23 and the company's stock closed 1.64% below its 52-week high. source